Notice of Change to PAR-23-021, "Avenir Award Program for Genetic or Epigenetic of Substance Use Disorders (DP1 Clinical Trial Optional)"
National Institutes of Health
Type
Research/project funding
Posted on:
Notice NOT-DA-24-062 from the NIH Guide for Grants and Contracts